Stay updated with breaking news from Alanc moss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tofacitinib achieves higher clinical and biochemical remission rates than vedolizumab for patients with anti-TNF-exposed ulcerative colitis, although the effect diminishes over time, say Dutch scientists. ....